ISSN 1725-2423

doi:10.3000/17252423.C_2011.234.eng

Official Journal

of the European Union

C 234

European flag  

English edition

Information and Notices

Volume 54
10 August 2011


Notice No

Contents

page

 

II   Information

 

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

 

European Commission

2011/C 234/01

Non-opposition to a notified concentration (Case COMP/M.6297 — Sealed Air/DHI) ( 1 )

1

2011/C 234/02

Non-opposition to a notified concentration (Case COMP/M.6189 — Imerys/Rio Tinto Talc Business) ( 1 )

1

2011/C 234/03

Non-opposition to a notified concentration (Case COMP/M.6322 — Carlyle/RAC) ( 1 )

2

2011/C 234/04

Initiation of proceedings (Case COMP/M.6166 — Deutsche Börse/NYSE Euronext) ( 1 )

2

 

IV   Notices

 

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

 

European Commission

2011/C 234/05

Euro exchange rates

3

2011/C 234/06

Commission Decision of 9 August 2011 on appointing members of the Committee for Orphan Medicinal Products ( 1 )

4

 

V   Announcements

 

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

 

European Commission

2011/C 234/07

Prior notification of a concentration (Case COMP/M.6210 — VFE Commerce/CDC/JV) — Candidate case for simplified procedure ( 1 )

5

 


 

(1)   Text with EEA relevance

EN

 


II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

10.8.2011   

EN

Official Journal of the European Union

C 234/1


Non-opposition to a notified concentration

(Case COMP/M.6297 — Sealed Air/DHI)

(Text with EEA relevance)

2011/C 234/01

On 2 August 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6297. EUR-Lex is the on-line access to the European law.


10.8.2011   

EN

Official Journal of the European Union

C 234/1


Non-opposition to a notified concentration

(Case COMP/M.6189 — Imerys/Rio Tinto Talc Business)

(Text with EEA relevance)

2011/C 234/02

On 7 July 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6189. EUR-Lex is the on-line access to the European law.


10.8.2011   

EN

Official Journal of the European Union

C 234/2


Non-opposition to a notified concentration

(Case COMP/M.6322 — Carlyle/RAC)

(Text with EEA relevance)

2011/C 234/03

On 3 August 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6322. EUR-Lex is the on-line access to the European law.


10.8.2011   

EN

Official Journal of the European Union

C 234/2


Initiation of proceedings

(Case COMP/M.6166 — Deutsche Börse/NYSE Euronext)

(Text with EEA relevance)

2011/C 234/04

On 4 August 2011, the Commission decided to initiate proceedings in the abovementioned case after finding that the notified concentration raises serious doubts as to its compatibility with the common market. The initiation of proceedings opens a second phase investigation with regard to the notified concentration, and is without prejudice to the final decision on the case. The decision is based on Article 6(1)(c) of Council Regulation (EC) No 139/2004.

The Commission invites interested third parties to submit their observations on the proposed concentration to the Commission.

In order to be fully taken into account in the procedure, observations should reach the Commission not later than 15 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301 / 22967244) or by post, under reference COMP/M.6166 — Deutsche Börse/NYSE Euronext, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

10.8.2011   

EN

Official Journal of the European Union

C 234/3


Euro exchange rates (1)

9 August 2011

2011/C 234/05

1 euro =


 

Currency

Exchange rate

USD

US dollar

1,4267

JPY

Japanese yen

110,24

DKK

Danish krone

7,4497

GBP

Pound sterling

0,87310

SEK

Swedish krona

9,2127

CHF

Swiss franc

1,0594

ISK

Iceland króna

 

NOK

Norwegian krone

7,8295

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,220

HUF

Hungarian forint

274,70

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7092

PLN

Polish zloty

4,0956

RON

Romanian leu

4,2625

TRY

Turkish lira

2,5164

AUD

Australian dollar

1,3990

CAD

Canadian dollar

1,4143

HKD

Hong Kong dollar

11,1401

NZD

New Zealand dollar

1,7329

SGD

Singapore dollar

1,7329

KRW

South Korean won

1 555,96

ZAR

South African rand

10,3710

CNY

Chinese yuan renminbi

9,1745

HRK

Croatian kuna

7,4550

IDR

Indonesian rupiah

12 251,94

MYR

Malaysian ringgit

4,3193

PHP

Philippine peso

60,611

RUB

Russian rouble

42,3780

THB

Thai baht

42,725

BRL

Brazilian real

2,3138

MXN

Mexican peso

17,7385

INR

Indian rupee

64,5010


(1)  Source: reference exchange rate published by the ECB.


10.8.2011   

EN

Official Journal of the European Union

C 234/4


COMMISSION DECISION

of 9 August 2011

on appointing members of the Committee for Orphan Medicinal Products

(Text with EEA relevance)

2011/C 234/06

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (1), and in particular Article 4(3) thereof,

Having regard to the recommendation of the European Medicines Agency of 25 May 2011,

Whereas:

(1)

The term of office of two members of the Committee for Orphan Medicinal Products which were appointed by the Commission on the recommendation from the European Medicines Agency expired in July 2011.

(2)

The European Medicines Agency has recommended the reappointment of these persons.

(3)

The members of the Committee shall be appointed for a period of three years starting on 1 September 2011,

HAS DECIDED AS FOLLOWS:

Sole Article

On the recommendation of the European Medicines Agency, the following are hereby reappointed members of the Committee for Orphan Medicinal Products for a term of three years from 1 September 2011:

 

Prof. János BORVENDÉG

 

Prof. Bruno SEPODES

Done at Brussels, 9 August 2011.

For the Commission

John DALLI

Member of the Commission


(1)  OJ L 18, 22.1.2000, p. 1.


V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

10.8.2011   

EN

Official Journal of the European Union

C 234/5


Prior notification of a concentration

(Case COMP/M.6210 — VFE Commerce/CDC/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

2011/C 234/07

1.

On 2 August 2011, the Commission received notification pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) of a proposed concentration by which the undertakings VFE Commerce, controlled by SNCF (France), and Caisse des Dépôts et Consignation (‘CDC’, France) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of a newly created company constituting a joint venture by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

VFE Commerce and SNCF: rail passenger and freight transport services and management of the French railway infrastructure,

CDC: tasks of general interest consisting in (i) managing private funds for which public authorities wish to provide special protection, and (ii) lending or investing in activities for the public interest. Its activities include personal insurance, transport, real estate and the development of companies and services.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6210 — VFE Commerce/CDC/JV, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).